What is an expected benefit of routine use of vaccines against human papillomavirus (HPV)?

Updated: Feb 20, 2020
  • Author: Peter A Gearhart, MD; Chief Editor: Pranatharthi Haran Chandrasekar, MBBS, MD  more...
  • Print

Routine use of the vaccine may be expected to reduce the incidence of HPV-associated anogenital diseases in young women. In 2009, a sexual health center in Australia reported a rapid and marked reduction in the incidence of genital warts among vaccinated women. This benefit was extended to heterosexual males, in that fewer men presented to this health center with genital warts. [102] The HPV vaccine is neither intended nor proved to treat genital warts. [103]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!